Trial Search Results

Ambulatory Alcohol Detoxification With Remote Monitoring

This study is designed to examine the feasibility and impact of the use of remote monitoring devices during an outpatient ambulatory alcohol detoxification treatment for patients with alcohol use disorders.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: SoberLink, LLC

Stanford Investigator(s):

Intervention(s):

  • Device: Remote Monitoring with Ambulatory Detox

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Male or female Subject between the ages of 21-75 years old

   - Meeting DSM-V criteria for alcohol use disorder and needing medically supervised
   detoxification based on medical history and pattern of alcohol use delineated by
   timeline follow back method.

   - Has 24/7 easy access to a hospital. This is to ensure easy admission to a higher level
   of care if indicated.

   - Willing to use the Soberlink Device to provide blood alcohol concentration (BAC)

   - Willing to use the blood pressure cuff to provide blood pressure and pulse (BPPT)
   measurement

   - Willing to sign an informed consent

Exclusion Criteria:

   - BAC above the legal driving limit at the time of screening

   - Developing symptoms or history of symptoms of severe withdrawal syndrome such as
   fever, disorientation, drenching sweats, severe tachycardia, or severe hypertension

   - History of delirium tremens or seizures

   - Co-morbid medical or psychiatric history requiring inpatient admission for careful
   monitoring

   - Subject unwilling to respond to redirection when blood pressure and heart rate warning
   signs are triggered

   - Does not have an iPhone, iPod, iPad, or Apple Watch with iOS 7.0 or later, or does not
   have an Android phone or tablet with Android 4.4 or later

   - Unable or unwilling to properly use the monitoring devices, or find the monitoring
   devices an obstruction to comply with treatment

   - Subject that is non-English speaking

   - Subject that is a child, adolescent, or cognitively impaired

Ages Eligible for Study

21 Years - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Amer Raheemullah, MD
Not Recruiting